Population Sensitive to Lenvatinib Plus Anti-PD-1 for Unresectable Hepatocellular Carcinoma Infected with Hepatitis B Virus

Population Sensitive to Lenvatinib Plus Anti-PD-1 for Unresectable Hepatocellular Carcinoma Infected with Hepatitis B Virus

Xiujuan Chang,1,* Shumin Yu,2,* Jianzhi Pang,1 Wei Zhang,1 Huifang Kong,1 Jiagan Huang,1 Guojie Zhang,1 Huixin Zhang,1 Yueyue Gu,1,3 Yan Chen,1 Bin Yang,1 Jingping Liu,4 Zhen Zeng1– 3 1Department of Liver Disease Medicine, The Fifth Medical Center of Chinese PLA General Hospital, Bei...

Full description

Bibliographic Details
Main Authors: Chang X, Yu S, Pang J, Zhang W, Kong H, Huang J, Zhang G, Zhang H, Gu Y, Chen Y, Yang B, Liu J, Zeng Z
Format: Article
Language:English
Published: Dove Medical Press 2023-06-01
Series:Journal of Hepatocellular Carcinoma
Subjects:
hepatocellular carcinoma
real-world study
anti-pd-1
lenvatinib
Online Access:https://www.dovepress.com/population-sensitive-to-lenvatinib-plus-anti-pd-1-for-unresectable-hep-peer-reviewed-fulltext-article-JHC

Internet

https://www.dovepress.com/population-sensitive-to-lenvatinib-plus-anti-pd-1-for-unresectable-hep-peer-reviewed-fulltext-article-JHC

Similar Items